
David D'Alessio
Internal Medicine Residency · Duke University Hospital
Credentials: · · ·
History
Research
Diabetes Care · 2018 · 1,964 citations
Glucagon-like peptide 1 (GLP-1)
Review · Molecular Metabolism · 2019 · 1,464 citations
Diabetes Care · 2020 · 876 citations

26 papers
- JT
Jenny Tong
24 papers
- RP
20 papers

19 papers · 12 as a fellow

18 papers

12 papers

9 papers
- JR
8 papers
Grants
- 2025–2030
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $1.6M · Duke University
- 1975–2029
Endocrinology and Metabolism Training Program
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $3.4M · Duke University
- 2024–2029
Alpha- to Beta-Cell Communication in Health and Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $1.9M · Duke University
- 2020–2025
Novel Metabolic Actions of GIP
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.1M · Duke University
Clinical trials
- 2026–2029
Studies of Insulin and Glucagon Action in the Liver
Principal investigator · Not yet recruiting · Phase 1, Phase 2
Duke University
- 2025–2027
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.
Principal investigator · Recruiting · Phase 1
David D'Alessio, M.D.
- 2019–2021
Glucagon Regulation of Glucose Metabolism
Principal investigator · Completed · Phase 1
David D'Alessio, M.D.
- 2018–2021
Regulation of Insulin Secretion by the GLP-1 Receptor
Principal investigator · Terminated · Phase 4
VA Office of Research and Development





